Kent D Stewart

This inventor holds 31 USPTO granted patents and 9 published patent applications, plus 10 CIPO patents and 11 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Abbott Laboratories Corporation, Abbvie Inc., Abbvie Deutschland Gmbh and Co Kg. Active years: 2001-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kent D Stewart. Retrieved from https://idiyas.com/inventor/kent-d-stewart

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 (Patent Applications = 9)

% Patents Active = 71.0

CIPO Patents = 10 (Patent Applications = 7)

EPO Patents = 11 (Patent Applications = 17)

Average Co-Inventor Count = 10.1

ph-index = 11

Forward Citations = 453(Granted Patents)

Location History:

Gurnee, IL (2014)
Gurnee, IL (US) (2001 - 2018)
Charlotte, NC (US) (2019)

Company Filing History:

19 out of 4,189

Abbott Laboratories Corporation

Abbvie Deutschland Gmbh and Co Kg

patents

where one patent can have more than one assignee

Years Active: 2001-2019

Loading Chart...

Areas of Expertise:

Tricyclic Compounds

Heterocyclic Compounds

Glycogen Synthase Kinase Inhibitors

Anti-Infective Agents

Pharmaceutical Compositions

Dipeptidyl Peptidase-IV

Neuraminidase Inhibitors

Urokinase Inhibitors

Serine Protease Reagents

Antiviral Compounds

Kinase Inhibitors

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE47221 - Tricyclic compounds (2019-02-04),

2. 9856234 - Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors (2018-01-02),

3. 9365579 - Tricyclic compounds (2016-06-14),

4. 9139536 - Anti-infective agents and uses thereof (2015-09-22),

5. 9095590 - Anti-infective agents and uses thereof (2015-08-04),

6. 8986740 - Anti-infective agents and uses thereof (2015-03-24),

7. 8962629 - Tricyclic compounds (2015-02-24),

8. 8741914 - Antiviral compounds and uses thereof (2014-06-03),

9. 8685991 - Anti-infective agents and uses thereof (2014-04-01),

10. 8642598 - Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors (2014-02-04),

11. 8637546 - Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DDP-IV) (2014-01-28),

12. 8501238 - Anti-infective agents and uses thereof (2013-08-06),

13. 8426411 - Tricyclic compounds (2013-04-23),

14. 8415351 - Anti-infective agents and uses thereof (2013-04-09),

15. 8188104 - Anti-infective agents and uses thereof (2012-05-29),

Title: The Innovative Contributions of Kent D. Stewart

Introduction

Kent D. Stewart, based in Gurnee, IL, is a prominent inventor with a remarkable portfolio of 31 patents. His work primarily focuses on the development of pharmaceutical compounds, particularly in the realms of immunology and oncology. Through his innovative contributions, Stewart has made significant strides in the field of medicinal chemistry.

Latest Patents

Stewart's latest inventions include the development of tricyclic compounds, which encompass pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers, and related isomers. These compounds are designed to be effective in treating various immunological and oncological conditions. Another noteworthy patent addresses the use of heterocyclic compounds as glycogen synthase kinase 3 (GSK-3) inhibitors. This patent details methods for preparing these compounds, their pharmaceutical compositions, and their therapeutic applications.

Career Highlights

Throughout his career, Kent D. Stewart has played an instrumental role at leading companies in the pharmaceutical sector, including Abbott Laboratories Corporation and AbbVie Inc. His work at these prestigious organizations has been foundational in advancing drug development and therapeutic interventions.

Collaborations

Stewart has collaborated with several esteemed colleagues, including Todd Warren Rockway and Clarence J. Maring. Together, they have contributed to the enhancement of pharmacological sciences, leveraging their collective expertise to create impactful innovations.

Conclusion

Kent D. Stewart's extensive patent portfolio and his collaborations within the pharmaceutical industry underscore his commitment to advancing medical science. His innovative inventions continue to pave the way for new treatments, demonstrating the essential role inventors play in improving healthcare outcomes.

Profile summary based on public USPTO records.